9th Nursing & Allied Health Symposium: Session 1: Cellular Therapies: Building Equity of Access

Chair(s)

• WB

  Wendy Bursey, RN CON(c) (she/her/hers)

  Oncology Nurse Case Manager
  Juravinski Cancer Centre, Ontario, Canada
• 

  Charise Gleason, NP-C

  VP and Chief APP Officer of Emory Healthcare
  Winship Cancer Institute of Emory University
  Stone Mountain, Georgia

Presentations:

• 08:50 - 09:05 East Coast USA Time

  Optimal Delivery of Bispecific Antibodies for Patients with MM
  

  Speaker: Chantelle Hughes, RN, MNursSci (she/her/hers) – University College London Hosptial
• 09:05 - 09:20 East Coast USA Time

  Shared care model of delivering cellular therapies
  

  Speaker: Mary Steinbach, DNP – Huntsman Cancer Institute/University of Utah
• 09:20 - 09:35 East Coast USA Time

  Outpatient/hybrid delivery of cellular therapies
  

  Speaker: Sara A. Scott, PharmD, BCOP (she/her/hers) – Winship Cancer Institute, Emory University
• 09:55 - 10:05 East Coast USA Time

  (NSO-01) Supporting the Shift: Inpatient Review of BCMA CAR-T Therapy in Multiple Myeloma Reveals Early Safety and Feasibility for a Nurse Lead Outpatient Model of Care
  

  Abstract Presenter: Ty Simpson, RN (he/him/his) – The Alfred Hospital
• 10:05 - 10:15 East Coast USA Time

  (NSO-02) Improving Capacity in the Malignant Hematology Day Unit by Increasing Subcutaneous Immunoglobulin Replacement Treatment in the Community
  

  Abstract Presenter: Dior Caruso, MN-NP Adult, CHPCN(C) – Princess Margaret Cancer Centre
• 10:15 - 10:25 East Coast USA Time

  (NSO-04) Patient Perspectives of Receiving Out-patient Step-up Dosing with Bispecific Antibodies (BsAb) for Relapsed Multiple Myeloma (MM)
  

  Abstract Presenter: Jennifer Russell, MSc, BSc (Hons) – University College London Hospital